Flubendazole-induced apoptosis was dependent on caspase activation in breast cancer [23, 24], and we also determined that flubendazole can up-regulate the pro-apoptotic protein Bax and downregulate the anti-apoptotic protein Bcl-2 in TNBC [26]. Here, BCL2 is linked to breast carcinoma.